HLS.AX

Healthcare Diagnostics & Research

Healius Limited

A$0.41

+0.00 +0.00% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 7, 2026, live at 3:35 PM ET	0.41

Key Stats

Market Cap

297.73M

Avg Volume

4.82M

EPS

-A$0.56

52W High

A$1.07

52W Low

A$0.30

Div. Yield

0.0%

Analyst Ratings

Hold

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

131.41

P/B Ratio

1.74

P/S Ratio

0.22

EV/EBITDA

20.52

EV/Revenue

0.89

PEG Ratio

1.60

Margins

Gross Margin 31.2%

Operating Margin 2.2%

Net Margin (30.3%)

EBITDA Margin 4.4%

Growth & Returns

Return on Equity

(107.7%)

Return on Assets

1.2%

Liquidity & Leverage

Current Ratio

0.66

Quick Ratio

0.54

Debt / Equity

5.81

Total Cash

67.20M

Total Debt

996.40M

About

Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab Dermatopathology, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.